Enteral Feeding Devices Market Growth Outlook Trends, and Forecast by 2032

Market Overview

The global Enteral Feeding Devices Market size is predicted to meet the market value of USD 6.01 Billion by 2032 at a 5.10% CAGR for the forecast period of 2023 to 2032, according to the latest research report from Market Research Future (MRFR). The global enteral feeding devices market is profiled in detail in the report, which provides a comprehensive overview of the market’s leading drivers and restraints as well as the leading players operating in the market.

Enteral feeding devices are used to feed people who, permanently or temporarily, have lost the ability to feed themselves due to the disease or disorder. Enteral feeding devices are used to directly deliver nutrients into some part of the small intestine or stomach, so that at-risk patients can be fed under complete supervision. Enteral feeding devices also allow doctors to monitor and manage the temporary nutrition of specific individuals in order to make sure they are being fed as much and what they should be fed, considering specific diseases and disorders. The growing geriatric population around the world is likely to be a major driver for the global enteral feeding devices market over the forecast period, as the geriatric population is likely to be a major consumer of technologies that allow them to be fed without the hassle of physically feeding themselves. The growing number of geriatric individuals suffering from neurodegenerative diseases is also likely to be a major driver for the global Enteral Feeding Devices Market.

Segmentation:

The global enteral feeding devices market has been segmented on the basis of product, age group, indication, end user, and region. 

·       By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

·       On the basis of age group, the market has been divided into adults and pediatrics. 

·       By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. 

·       Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). 

Major players in the global enteral feeding devices market are likely to focus on developing products that fit regulatory standards and enable steady growth for the company in the market. The growing scope for the medical devices sector in Asia Pacific is likely to be a key factor for the global enteral feeding devices market over the forecast period. 

Competitive Analysis:

Leading Enteral Feeding Devices Market Players include:  

§  Medtronic plc,

§  Cook Medical,

§  B. Braun Melsungen AG,

§  Abbott Laboratories,

§  Boston Scientific Corporation,

§  Becton,

§  Dickinson and Company (BD),

§  Fresenius Kabi AG,

§  Danone Nutricia,

§  Nestlé,

§  CONMED Corporation,

§  Moog, Inc.,

§  Halyard Health, Inc., and

§  Vygon SA.

Regional Analysis:

The Americas dominates the global enteral feeding devices market, followed by Europe. Asia Pacific is also likely to grow at a high CAGR over the forecast period. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013               

Psychedelic Drugs Market: The Impact of COVID-19

 

The global psychedelic drugs market is expected to grow at a significant growth during the forecast period of 2018-2032. This growth can be attributed to a number of factors, including:

• Increasing awareness and acceptance of psychedelic drugs for the treatment of mental health disorders
• Rising prevalence of mental health disorders, such as depression and anxiety
• Growing research into the therapeutic potential of psychedelic drugs
• Increasing government support for psychedelic drug research and development

Regional Overview

The global psychedelic drugs market is segmented into four geographic regions: North America, Europe, Asia Pacific, and Rest of the World (RoW).

Subscribe to get Comprehensive Data Insights:

Rest of the World (RoW) is the smallest market for psychedelic drugs, accounting for less than 5% of the global market share in 2022. The market in RoW is expected to grow at a moderate pace in the coming years, due to the increasing awareness and acceptance of psychedelic drugs in the region.

Itali psychedelic drugs market is the largest market for psychedelic drugs, accounting for over 50% of the global market share in 2022. This is due to the increasing legalization and acceptance of psychedelic drugs in the region, as well as the presence of a number of leading psychedelic drug companies.

France psychedelic drugs market is the second-largest market for psychedelic drugs, accounting for over 30% of the global market share in 2022. The market in Europe is expected to grow significantly in the coming years, due to the increasing legalization and acceptance of psychedelic drugs in the region, as well as the growing research into the therapeutic potential of psychedelic drugs.

Spain psychedelic drugs market is the third-largest market for psychedelic drugs, accounting for over 15% of the global market share in 2022. The market in Asia Pacific is expected to grow at a rapid pace in the coming years, due to the increasing awareness and acceptance of psychedelic drugs in the region, as well as the growing prevalence of mental health disorders.

Key Trends in the Global Psychedelic Drugs Market

Some of the key trends in the global psychedelic drugs market include:

• Increasing investment in psychedelic drug research and development
• Growing interest from pharmaceutical companies in psychedelic drugs
• Increasing legalization and acceptance of psychedelic drugs
• Growing demand for psychedelic drugs for the treatment of mental health disorders

Key Challenges in the Global Psychedelic Drugs Market

Some of the key challenges in the global psychedelic drugs market include:

• Strict regulations on psychedelic drugs
• Lack of awareness about the therapeutic potential of psychedelic drugs
• Negative public perception of psychedelic drugs

Overall, the global psychedelic drugs market is expected to grow at a significant CAGR in the coming years. This growth is being driven by a number of factors, including the increasing awareness and acceptance of psychedelic drugs, the rising prevalence of mental health disorders, and the growing research into the therapeutic potential of psychedelic drugs.

Related Charts:

U.S. Psychedelic Drugs Market Outlook (2018 to 2032) 

Canada Psychedelic Drugs Market Outlook (2018 to 2032) 

Germany Psychedelic Drugs Market Outlook (2018 to 2032) 

U.K.  Psychedelic Drugs Market Outlook (2018 to 2032) 

About Us

Wantstats Research and Media Pvt Ltd is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. WRMPL’s approach combines the proprietary information with various data sources to give an extensive understanding to the client about the latest key developments, expected events and also about what action to take based on these aspects.

Our fast growing industry research firm is backed by a proficient team of research analysts that offers valuable analytics and data with respect to technological and economical advancements. Our deemed analysts perform industrial visits and procure the relevant information from prominent market players. Our key objective is to keep our clients abridged of the potential opportunities and challenges in different markets. We provide step-by-step assistance to our respected clients, via strategic and consulting services to reach a managerial and actionable decision.

Contact Details

Corporate Office (India)

WantStats Research and Media Pvt. Ltd.

Office No 104, Pentagon 4,

Magarpatta City, Pune - 411028

Maharashtra, India.

Sales: +1 (855) 661-4441 (US)   +44 1720 412 167(UK)

Erythropoietin Drugs Market Outlook : A Forecast of the Market Share, and Trends

Market Overview

Also known as hematopoietin, erythropoietin drug is defined as a glycoprotein hormone that controls erythropoiesis. Erythropoiesis is defined as the production of red blood cells (RBC). A new report on the global erythropoietin drug market share is projected to grow at a CAGR of 11.2% during the forecast period 2023-2032.

The most significant market driving factor for the global erythropoietin drug market growth is the increasing prevalence of diseases like cancer and various renal diseases. The increasing investment in medical research & development (R&D) and introduction of new drugs are also carrying forward the market growth. Noth just new drugs but the market is also getting strong due to the introduction of several new erythropoietin drug combinations. Other factors contributing to the global erythropoietin drug market growth include different government initiatives for research and a wider pool of patients being covered due to the introduction of new drug combinations.

Key Players

the global erythropoietin drug market players are 3SBio (China), Amgen (USA), Biocon (India), Biosidus (Argentina), Boehringer Ingelheim (USA), Celltrion Inc. (South Korea), Dahua Pharmaceutical (China), Emcure Pharmaceuticals (India), Hoffmann-La Roche (Switzerland), Hospira (USA), Intas Pharmaceuticals (India), Johnson & Johnson (USA), Kyowa Hakko Kirin (Japan), LG Life Sciences Ltd. (South Korea), and Teva Pharmaceutical Industries Ltd. (Israel).

Market Segmentation

The global erythropoietin drug market outlook encompasses application, end-user, and product type. MRFR’s take on the market surveys various facets of the market in-depth.

The application-based segmentation of this market covers the Human Immunodeficiency Virus (HIV), oncology, renal diseases, and others. In the context of end-user, the market has been segmented into hospital and pharmacy. Regarding product type, the market has been segmented into biosimilars, first-generation formulation, and second-generation formulation.

Regional Segmentation

A geographical outlining of the global erythropoietin drug market covers North America, Europe, Asia Pacific, and the Middle East & Africa (MEA).

North America holds the largest share in the global market due to continuously increasing number of the cancer patient, technological advancement in the medical sector, availability of advanced medical services, governmental initiatives for research, and patient suffering from renal diseases in North America. USA and Canada generate maximum market revenue in this region. Some of the key market players are based in the USA.

In Europe, the market is growing primarily due to the same reasons as in North America. Amendments in reimbursement policies and the growing healthcare sector are also contributing to the market growth. Due to the availability of advanced medical facilities, Western Europe is a bigger regional market than Eastern Europe. The most powerful country-specific markets in Europe are France, Germany, Italy, Spain, and the UK. An inspection of the remaining countries in Western Europe featured in this report speculate the huge contribution to market revenue from some other countries in this region with a sizable revenue from Eastern Europe too.

During the forecast period, the gains for Asia Pacific market can rise high, making it the fastest-growing regional market. The factors benefitting the market growth in this region are increased penetration of healthcare services and expanding patient population in countries like China and India. Moreover, the increased government effort to improve healthcare in these countries is creating new growth opportunities for the market. Other important country-specific markets in this region are Australia, Japan, and South Korea. An analysis of the remaining countries in the Asia Pacific region featured in this report estimates the huge contribution to market revenue from some other countries.

The MEA region holds the lowest share in the global market due to poor medical facilities and lack of skilled professionals.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Contraceptive Pills Market Insights Overview, Industry Analysis and Forecasts Report 2032

 

Market Synopsis:

According to the report, the Contraceptive Pills Market Size was valued at USD 20.9 billion in 2022 and is projected to grow from USD 21.4 Billion in 2023 to USD 25.38 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 2.2% during the forecast period (2023 - 2032).

Contraceptive pills are likely to witness considerable demand in the years to come. The observation offered by Market Research Future (MRFR) unfolds that the global Contraceptive Pills Market Insights is expected to enter a phase of maturity in the foreseeable future.

The issue of problem explosion has encouraged the increasing consumption of contraceptive pills. It has motivated the governments to invest in its distribution for market penetration. In addition, non-profit organizations are also expected to support the use of pills. These factors are expected to expedite the revenue growth of the contraceptive pills market in the years to come. The social awakening regarding the use of these pills supported by organizations is expected to lead the growth of the market in the forthcoming years.

The ongoing protest against abortion has escalated serious concerns regarding accidental pregnancies. This, in turn, is projected to shed light on the pills as a safer option, thus, supporting its increased sales. Also, the easier access to the product is likely to catapult the contraceptive pills market on upward trajectory. However, the availability of alternatives such as condom is expected to check the expansion of the contraceptive pills market over the next couple of years. Increasing awareness about the availability of alternatives is poised to restrict the market growth in the years to come.

Contraceptive pills cause several side effects such as a change in gynecological issues, hormonal imbalance, etc. Some of these pills, especially emergency contraceptive pills, can adversely affect the fecundity of women. This, in turn, is projected to check the expansion of the contraceptive pills market over the next few years. However, the research & development of male contraceptive pills is likely to have a positive impact on market growth in the forthcoming years.

Contraceptive Pills Market Overview and Size, Trends and Growth Outlook by Type [Oral Contraceptives (Combined Oral Contraceptive Pills and Progestogen-Only Pills), Topical Contraceptives, Contraceptive Injectables and others], Distribution Channel (Hospital & Clinics, Retail Pharmacy, Online Pharmacy and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa)

 

Competitive Dashboard:

Pharmaceuticals,

HLL Life Care,

Sopharma AD,

V Care Pharma, and

Ferring B.V

are some of the Contraceptive Pills Market Players. These players are expected to contribute significantly to the expansion of the market in the years to come.

Market Segmentation:

This MRFR report includes a detailed segmental analysis of the global Contraceptive Pills Market Trends based on drug class. The segments of the market include monophasic, triphasic, and others.

Study objectives of Contraceptive Pills Market:

• To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Contraceptive Pills market  
• To provide insights about factors affecting the market growth
• To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
• To provide country level analysis of the market with respect to the current market size and future prospective
• To provide country level analysis of the market for segments by drug class, and its sub-segments.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Contraceptive Pills market.

Regional Analysis:

The report presents an exhaustive regional assessment of the global Contraceptive Pills Market Outlook for offering an informative insight. These segments, on the basis of region, are Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific. Americas is the leading the expansion of the global market and is anticipated to maintain its control over the maximum market share in the foreseeable future. The latest regulations in some of the states of the U.S. against abortion is anticipated to boost the sales of contraceptive in the years to come.

Europe contraceptive pills market is also projected to exhibit considerable growth at the second spot in the upcoming years. Increasing awareness about the product is the key factor responsible for catalyzing expansion of the contraceptive pills in the market over the assessment period. Meanwhile, Asia Pacific is likely to register the highest CAGR across the forecast period.

The market scenario represents healthy competition. Increasing investments in research & development by the key players are poised to boost revenue creation in the contraceptive pills market in the forthcoming years. The emphasis is on the minimization of adverse effects of the pills and ensuring cent percent results. Product development is likely to drive the growth of the contraceptive pills market over the next couple of years. In addition, other growth trajectories are also being trodden by the market participants for acceleration of revenue growth. Some of these growth strategies are mergers & acquisitions, partnerships, collaborations, etc.

Related Reports-

Dental Surgical Devices Market Research Report- Global Forecast till 2030

Hearing Aids Market Research Report - Forecast till 2030

Flow Cytometry Market Research Report –Forecast to 2030

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Vascular Patches Market Insights, Growth Analysis, CAGR Status & forecast to 2032

 

Market Analysis

The global vascular patches market size is poised to touch at a notable 8.0% CAGR over the predicted years 2023-2032. Vascular patches are utilized in vascular surgeries for closing sutures. In every surgical procedure, the primary closure of sutures needs to be done effectively. Vascular patches are made from synthetic or biological materials and are characterized through excellent biocompatibility. Of the different types, it is the biological vascular patches that are most widely used owing to its various advantages such as excellent biocompatibility, low suture line bleeding, minimum infection rate and ease in use.

There are plentiful factors that is boosting the growth of the vascular patches market. These factors as per the Market Research Future (MRFR) report include rapidly increasing geriatric population, prevalence of vascular diseases, growing number of vascular surgeries being performed, growing use of biological patches, need for minimally invasive surgeries and increasing product launches and research and development investments. On the contrary, scarcity of skilled professional, mishandling, decrease in carotid endarterectomy surgeries owing to low preference are factors that may restrict the growth of the vascular patches market.

Key Players

Vascular patches market players are include Baxter International Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), Labcor Laboratórios Ltda (Brazil), Admedus (Australia), CryoLife, Inc. (U.S.), W. L. Gore & Associates, Inc. (US), LeMaitre Vascular, Inc. (U.S.), Maquet (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), C.R. Bard, Inc. (U.S.) and others.

Market Segmentation

MRFR report provides an extensive segmental analysis of the vascular patches market on the basis of application, material and end-user.

Based on material, it is segmented into synthetic vascular patches and biologic vascular patches. Of these, the biologic vascular patches will have the maximum share in the market over the predicted years followed by synthetic vascular patches that will grow at the fastest pace.

Based on application, the vascular patches market is segmented into open repair of abdominal aortic aneurysms vascular bypass surgery and carotid endarterectomy. Of these, carotid endarterectomy will dominate the market followed by open repair of abdominal aortic aneurysms vascular bypass surgery which will grow at the fastest rate.

Based on end-user, it is segmented into ambulatory surgical centers, hospitals and clinics and others. Of these, hospitals and clinics will rule the market followed by ambulatory surgical centers that will grow at the fastest pace.

Regional Analysis

By region, the vascular patches market insights covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will domineer the market over the predicted years and is expected to expand at a substantial CAGR. The increasing occurrence of cardiovascular issues in Canada and the US, growing population and increasing per capita healthcare spending will boost the market growth in this region. Also, the rapid uptake of latest devices and technologies in the surgical procedure and the presence of key manufacturers is again boosting the market growth. The vascular patches market in Europe will have the second major share due to the resurging economy, growing awareness regarding vascular patches and procedure advancements and increasing per capita healthcare expenses. The vascular patches market in the APAC region will grow at the fastest pace over the predicted years owing to growing healthcare sector in India and China, increasing geriatric populace, growing awareness regarding healthcare and rising incidence of people suffering from various chronic coronary diseases.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Respiratory Therapeutic Devices Market Players, Segmentation & Analysis by Recent Trends

Market Highlights 

The Respiratory Therapeutic Devices Market Size is anticipated to reach USD 12,231.6 Million by 2030 at 8.6% CAGR during the forecast period 2022-2030. 

Respiratory therapeutic devices are used in the treatment, management, and control of cardiopulmonary diseases such as chronic obstructive pulmonary diseases (COPD), asthma, acute bronchitis, cystic fibrosis, and others. Increasing prevalence of asthma drives the market along with increasing per capita healthcare expenditure. According to the World Health Organization in 2017, approximately 235 million people have asthma. Moreover, it was estimated that in 2015, the diseases killed approximately 383 million patients around the globe. However, the market growth during the forecast period is likely to hamper due to low per capita income in the developing economies and lack of awareness.

Key Players

Global Respiratory Therapeutic Devices Market Players are

 

Masimo. (U.S.),

BD. (U.S.),

Smiths Group Plc. (U.S.),

F. Hoffmann-La Roche Ltd (Europe),

Bayer AG (Europe),

Rotech Healthcare Inc. (U.S.),

Chart Industries (U.S.),

Acare Technology (Asia Pacific), and

others.

Segmentation

The global respiratory therapeutic devices market is segmented on the basis of product, technology, application, and end users.

On the basis of the product, the market is segmented into nebulizers, capnography, humidifiers oxygen concentrators, and others. The nebulizers segment is sub-segmented into soft mist inhaler, human-powered nebulizer, and others. The capnography segment is sub-segmented into main-stream capnography, side-stream capnography, and others.

On the basis of the technology, the market is segmented into electrostatic filtration, HEPA filtration, hollow fiber filtration, microsphere separation, and others.

On the basis of the application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, retail pharmacies, home care, and others. 

Regional Analysis

The Americas dominate the global respiratory therapeutic devices market insights owing to a huge patient population having cardiopulmonary diseases and well-developed healthcare sector. Moreover, the concentration of the global players like Masimo., BD., Smiths Group plc., besides others along with the increasing healthcare expenditure fuels the regional market growth during the forecast period. In 2015, according to the Centers for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. 

Europe is the second largest respiratory therapeutic devices market owing to a well-developed healthcare infrastructure, government support for research & development, and huge patient population. In 2017, according to a study published in the Asthma Research and Practice Journal, the total estimated cost per year for all the asthmatics per patient is about USD 1,900. 

Asia Pacific is the fastest growing market due to the presence of a huge patient population, continuously developing economies like India and China, and the presence of huge opportunities in the market. Moreover, favorable government policies and increasing healthcare expenditure fuel the market within the region. 

On the other hand, the Middle East & Africa holds the least share of the global respiratory therapeutic devices market due to the presence of poor economy, especially, within the African region. Majority of the market of this region is held by the Middle East due to the huge healthcare expenditure. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013              

 

Laboratory Information Systems Market Insights Analysis By Segmentations, Key Players & Regional Analysis

Market Scenario

The global laboratory information systems size is projected to grow USD 3.8694 billion by 2030 at CAGR of 9.50% during the forecast period 2023-2030, predicts Market Research Future (MRFR). There are several practice applications of an LIS that improve the day-to-day operations of a medical laboratory, along with prevention of medical errors. A busy medical laboratory having many patients on a regular basis encounter difficulty in keeping all the patients’ information organized. Thus, an LIS system comes in handy, as it helps keep all this information organized, which is vitally important for a medical lab to run smoothly. Apart from this, rising integration of LIS and Electronic Health Record (EHR) and demand for quality and precision diagnosis are majorly supplementing the market growth globally. Moreover, increasing penetration of mobile applications in healthcare solutions coupled with growing popularity of cloud-based laboratory information system testifies for the market progress that has taken place in the past few years.

On the flip side, lack of skilled information technology (IT) professionals in the healthcare industry tames the flow of the progressing market. However, an array of opportunities stemming from emerging regions along with the consistently growing adoption of LIS are proof enough that the global market is en-route to brighter future prospects. Also noteworthy are few trends that bestow the global market with the required push, including proliferation of smartphones, point-of-care devices and e-services in the healthcare industry which significantly shape the market dynamics. Also, immense demand from patients for technological solutions for more convenient health testing, and monitoring is growing. This leads to global market players taking notice of the opportunities that crop up and indulge in strategic activities such as product launches. For instance, in the year 2014, Thermo Fisher launched a new ultracentrifuge which combines speed with safety and ergonomics that allows researchers to protect samples easily while also achieving reliable and consistent results.

Key Players

global laboratory information systems market players include   Cerner Corporation, Recent Developments, Eclipsys Corporation, Merge Healthcare Inc., STARLIMS Corporation, Sunquest Corporation and Thermo Fisher Scientific Inc., LabVantage Solutions Inc., LabWare Inc., McKesson Corporation, Medical Information Technology Inc., and others.

The Cerner EHR project is thriving as the U.S. Department of Defense increases its budget by about USD 1.2 billion. The additional funds will support the added services to maintain a standard EHR between the Department of Veterans Affairs and the U.S. Coast Guard. The EHR when integrated with laboratory information system, turns highly efficient, which leads to increased productivity and also reduced probability of errors. Cerner is an established company in the global LIS market that understands this fact and makes use of every opportunity to enhance its products to cater to various customer needs.

Market Segmentation

The laboratory information systems lis is segmented on the basis of application, components, and delivery.

By applications, the market is segmented based on clinical LIS, drug discovery LIS, and industrial LIS. The clinical application of LIS holds the largest market share as using LIS software involves more productivity and less paperwork, enhanced patient safety, and improved turn-around time.

By components, the market is segmented based on software, hardware, and services. Among these, the software segment accounts for the majority of the global LIS market due to increasing product enhancements and advent of innovative LIS software systems which ensures the smooth running of the healthcare department.

By delivery, the market is segmented on the basis of web-based, on-premise and cloud-based. Among these, cloud-based LIS software is highly popular as it offers various benefits such as cost savings, high security, flexibility, mobility and quality control.

Regional Analysis

By region, the global laboratory information systems market insights is segmented on the basis of North America, Europe, Asia Pacific and the Rest of the World (RoW).

The joint market share combining North America and Europe was more than 75% of the global total market size in 2014. However, North America has currently secured the top position claiming the largest market share. This stupendous growth can be attributed to increasing cases of fatal diseases and subsequent diagnostic and treatment needs. Moreover, high disposable income and strong economy also help augment the market growth in the region. Furthermore, increasing business opportunities for healthcare service providers along with growing demand for automated instruments rising in laboratories has majorly triggered the market growth in the region.

On the other hand, the Europe LIS market is estimated to grow tremendously during the forecast period, due to massive investment by healthcare IT players and a barrage of players trying to enter the regional market and establish themselves. Moreover, thriving healthcare industry and sophisticated medical infrastructure also play a major role in the growth of the regional market.

The Asia-marked Pacific is also presumed to grow at a significant pace throughout the forecast period. This growth is due to increased infectious diseases, significant increase in healthcare expenditure and advancements in healthcare IT sector. The market growth in the region is also aided by growing need for enhancing the efficiency of medical laboratories, growing demand for error-free diagnosis and increasing integration of information system with laboratories.

The rising aging population and increasing cases of fatal diseases in the regions of Middle East and Africa have propelled the market growth in the region. Also, the market in the region is highly fragmented, and the regional market players used various strategies such as product launches, expansions, and joint ventures to increase their footprint in the region. This gives a significant push to the market and will continue to do so in the coming years as well.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America